Presentation is loading. Please wait.

Presentation is loading. Please wait.

Lori Lombardi MD, Mark A. Terry MD, Neda Shamie MD, Anand K. Shah MD, Daniel J. Friend MS *Dr. Terry has a financial interest in Bausch & Lomb instruments.

Similar presentations


Presentation on theme: "Lori Lombardi MD, Mark A. Terry MD, Neda Shamie MD, Anand K. Shah MD, Daniel J. Friend MS *Dr. Terry has a financial interest in Bausch & Lomb instruments."— Presentation transcript:

1 Lori Lombardi MD, Mark A. Terry MD, Neda Shamie MD, Anand K. Shah MD, Daniel J. Friend MS *Dr. Terry has a financial interest in Bausch & Lomb instruments he developed for DSAEK Other authors have no financial interest

2  DSAEK surgery has revolutionized treatment for various forms of corneal endothelial dysfunction  Successful replacement of damaged endothelium with graft tissue relies on surgical technique as well as favorable tissue characteristics  Previously, surgeons prepared the donor posterior lenticule at the time of surgery  Now, “precut” donor tissue may be prepared by the tissue bank using a Moria microkeratome and artificial anterior chamber system

3  This large scale, prospective study compares outcomes of DSAEK surgery using surgeon-cut versus pre-cut donor tissue

4  Patients were enrolled in an Institutional Review Board approved protocol for endothelial keratoplasty  Surgical data was gathered in a prospective fashion  Consecutive DSAEK surgeries were compared using Surgeon-cut tissue (n=114) versus Pre-cut tissue (n=207).  Outcome measures reviewed include:  Best spectacle corrected visual acuity (BSCVA)  Endothelial cell loss  Rate of primary graft failure  Graft dislocation rate

5  Average BSCVA at 6 months:  20/37 for the Surgeon-cut group (n=114)  20/38 for the Pre-cut group (n=207)  p = 0.745  Average BSCVA at 1 year:  20/33 for the Surgeon-cut (n=108)  20/42 for the Pre-cut (n=112)  p = 0.044  With comorbidities removed, BSCVA at 1 year:  20/33 for the Surgeon-cut (n=106)  20/41 for Pre-cut (n=108)  p = 0.72

6

7  Endothelial cell loss at 6 months:  Surgeon-cut = 35%  Pre-cut = 29%  p=0.002  Endothelial cell loss at 1 year:  Surgeon-cut = 36%  Pre-cut = 29%  p = 0.009

8

9  Primary graft failures:  No primary graft failures occurred in either group  Dislocations:  Two dislocations occurred in the Surgeon-cut group  Ten dislocations in the Pre-cut group  p=0.421

10  In this large-scale, prospective study, DSAEK using either Surgeon-cut or Pre-cut tissue resulted in comparable patient outcomes and surgical results  BSCVA was not statistically different between groups  Endothelial loss was higher in Surgeon-cut tissue  Dislocations occurred more often in the Pre-cut group  Study includes graft preparation and surgery performed by less experienced surgeons, which may factor into the overall outcomes


Download ppt "Lori Lombardi MD, Mark A. Terry MD, Neda Shamie MD, Anand K. Shah MD, Daniel J. Friend MS *Dr. Terry has a financial interest in Bausch & Lomb instruments."

Similar presentations


Ads by Google